Which pharmaceutical product recall in 2004-2005 led to congressional hearings and resulted in significant changes to FDA oversight after being linked to approximately 60,000 excess cardiovascular events?

In the world of medicine, product recalls can have significant impacts on patient safety, company reputation, and the healthcare industry as a whole. Some recalls become particularly notable due to their scale, severity, or unexpected nature. Test your knowledge about one of the most significant pharmaceutical product recalls in medical history with this challenging question!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vioxx (rofecoxib) by Merck
Bextra (valdecoxib) by Pfizer
Baycol (cerivastatin) by Bayer
Rezulin (troglitazone) by Warner-Lambert